Arranon
These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON. ARRANON (nelarabine) injection, for intravenous use Initial U.S. Approval: 2005
Approved
Approval ID
fffa5d75-0dba-4ad7-a252-5f60fa28489a
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Sep 8, 2022
Manufacturers
FDA
Novartis Pharmaceuticals Corporation
DUNS: 002147023
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
nelarabine
PRODUCT DETAILS
NDC Product Code0078-0683
Application NumberNDA021877
Marketing CategoryC73594
Route of AdministrationINTRAVENOUS
Effective DateSeptember 8, 2022
Generic Namenelarabine
INGREDIENTS (3)
NELARABINEActive
Quantity: 5 mg in 1 mL
Code: 60158CV180
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT